Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- GALDERMA RES & DEV SNC
- Publication Date
- 2015-11-12
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of co-pending U.S. patent application Ser. No. 13 / 322,803 filed Feb. 7, 2012, which is a national stage application under 35 U.S.C. §371 of PCT Application No. PCT / EP2010 / 057493, filed May 28, 2010, which claims priority to and the benefit of U.S. provisional patent application Ser. No. 61 / 213,322, filed May 29, 2009, each of which is incorporated herein by reference in its entirety.FIELD OF THE INVENTION
[0002] The present invention is in the surgical and dermatological domain.
[0003] The present invention relates to an injectable composition comprising an adrenergic receptor agonist, preferably brimonidine, and a filler, preferably hyaluronic acid. It concerns its use in preventing and / or treating superficial bruising and bleeding caused by aesthetic procedures.BACKGROUND OF THE INVENTION
[0004] Superficial bruising and, to a lesser extent, bleeding are not uncommon consequences—reported on average about one...